Texas is poised to implement stringent new regulations on ketamine, a fast-acting sedative increasingly used to treat mental illness, sparking a fierce debate between medical authorities advocating for patient safety and providers concerned about limiting access to a vital therapy.
The proposed rules, which include heightened physician oversight during administration and a ban on in-home use, are slated for publication on May 8, with the Texas Medical Board scheduled to vote on the changes in June.
